文献速递消化道肿瘤与早癌消化内镜

基于首次内镜估算Barrett食管患者肿瘤检出率(NDR):系统综述与Meta分析

Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis.
PubMed 文献 · Gut · 2019-03-14

本系统综述与Meta分析纳入11项研究共10632例因慢性GERD症状行首次内镜并检出Barrett食管的患者,汇总分析高级别异型增生和食管腺癌的患病率即肿瘤检出率(NDR)。汇总NDR为7%(95%CI 4-10),结论认为NDR约为4%并可作为质量指标。

要点

  • 首次内镜检出Barrett食管患者中,汇总肿瘤检出率(NDR)为7%(95%CI 4-10)。
  • 食管腺癌汇总患病率为3%(95%CI 2-5),高级别异型增生为3%(95%CI 2-5)。
  • 结论认为NDR约为4%,可作为质量指标使用。

核心结论

  • NDR约为4%,可作为质量指标使用。

研究设计与样本

  • 系统综述与Meta分析,检索PUBMED、EMBASE和Cochrane Library数据库,纳入因慢性GERD症状行首次内镜评估Barrett食管存在的研究。
  • 共纳入11项研究、10632例患者,其中80.4%为男性,平均年龄58.7岁,平均Barrett食管长度为3.5 cm。
  • 由两名评价者独立评估研究合格性、方法学质量和数据提取,采用基于二项分布的随机效应模型计算汇总效应。

主要发现

  • 食管腺癌汇总患病率为3%(95%CI 2-5,9项研究:396/10539例患者)。
  • 高级别异型增生汇总患病率为3%(95%CI 2-5,随机效应模型,9项研究:388/10539例患者)。
  • 低级别异型增生汇总患病率为10%(95%CI 7-15,随机效应模型,10项研究:907/8945例患者)。
  • 肿瘤检出率即高级别异型增生/食管腺癌的汇总患病率为7%(95%CI 4-10,随机效应模型,10项研究:795/10632例患者)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biopsies are obtained to confirm intestinal metaplasia and rule out prevalent dysplasia and cancer when Barrett's oesophagus (BE) is detected at index upper endoscopy (oesophagogastroduodenoscopy [EGD]). AIM: The purpose of this systematic review was to obtain summary estimates of the prevalence of high-grade dysplasia (HGD) and oesophageal adenocarcinoma (EAC) associated with BE during index EGD for chronic GERD symptoms, defined as neoplasia detection rate (NDR) which could be used as a quality measure. METHODS: An extensive search was performed within PUBMED, EMBASE and the Cochrane Library databases to identify studies in which patients underwent index endoscopy for the evaluation of the presence of BE. Two reviewers independently evaluated both the study eligibility and methodological quality and data extraction. A random-effects model (REM) based on the binomial distribution was used to calculate the pooled effects of the prevalence of BE-associated dysplasia and EAC. RESULTS: For the calculation of dysplasia and EAC prevalence rates, a total of 11 studies with 10 632 patients met the inclusion criteria including 80.4% men with a mean age of 58.7 years and average BE length of 3.5 cm. The pooled prevalence of EAC, HGD and LGD was 3%(95% CI 2 to 5, 9 studies: 396/10 539 patients), 3%(95% CI 2 to 5 [REM], 9 studies: 388/10 539 patients) and 10%(95% CI 7 to 15 [REM], 10 studies: 907/8945 patients), respectively. For NDR, that is, the pooled prevalence of HGD/EAC was 7%(95% CI 4 to 10 [REM], 10 studies: 795/10 632 patients). CONCLUSION: NDR is approximately 4% and could be used as a quality measure.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Parasa S, Desai M, Vittal A, et al. Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis. Gut. 2019. PMID: 30872393. doi:10.1136/gutjnl-2018-317800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。